Literature DB >> 6832814

Reactivation of Chlamydia trachomatis lung infection in mice by cortisone.

Y S Yang, C C Kuo, W J Chen.   

Abstract

To study the latency, chronicity, and recurrent nature of chlamydial infection, we attempted to reactivate Chlamydia trachomatis lung infection in mice by immunosuppressive therapy with cortisone. Mice were treated with subcutaneous injections of cortisone acetate (125 mg/kg) every other day, starting on day 14 after intranasal inoculation of C. trachomatis serotype B (TW-5). C. trachomatis was recovered from the lungs beginning day 6 after the start of cortisone treatment until the end of the observation period on day 12 of treatment. Overall, the reactivation was successful in 8 of 55 mice treated with cortisone, in contrast to 0 of 41 inoculated, untreated mice (P = 0.009) and 0 of 35 uninoculated, treated mice. Cortisone treatment affected the ability of peritoneal exudate cells to respond to migratory inhibition after exposure to purified whole organisms of C. trachomatis serotype B (TW-5) but had little effect on serum antibody titers, indicating a possible role for cellular immunity in resistance against C. trachomatis infection in the lung.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832814      PMCID: PMC348001          DOI: 10.1128/iai.39.2.655-658.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS.

Authors:  J R DAVID; S AL-ASKARI; H S LAWRENCE; L THOMAS
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

Review 2.  Chlamydial infections (third of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

Review 3.  The regulatory role of macrophages in antigenic stimulation.

Authors:  E R Unanue
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

4.  Colony formation by mouse peritoneal exudate cells in vitro.

Authors:  H Lin; C C Stewart
Journal:  Nat New Biol       Date:  1973-06-06

Review 5.  Chemical suppression of adaptive immunity.

Authors:  A E Gabrielsen; R A Good
Journal:  Adv Immunol       Date:  1967       Impact factor: 3.543

6.  A mouse model of Chlamydia trachomatis pneumonitis.

Authors:  C Kuo; W J Chen
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

7.  Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture.

Authors:  R S Stephens; C C Kuo; M R Tam
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

8.  Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans.

Authors:  R C Brunham; D H Martin; C C Kuo; S P Wang; C E Stevens; T Hubbard; K K Holmes
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

9.  A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms.

Authors:  S P Wang; C C Kuo; J T Grayston
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

10.  Isolation of Chlamydia trachomatis from the lower respiratory tract of adults.

Authors:  K J Tack; P K Peterson; F L Rasp; M O'Leary; D Hanto; R L Simmons; L D Sabath
Journal:  Lancet       Date:  1980-01-19       Impact factor: 79.321

View more
  12 in total

Review 1.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

2.  Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice.

Authors:  Charles Pavia; Mario A Inchiosa; Gary P Wormser
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitro.

Authors:  N Tsumura; U Emre; P Roblin; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

4.  Reactivation of chlamydial genital tract infection in mice.

Authors:  T W Cotter; G S Miranpuri; K H Ramsey; C E Poulsen; G I Byrne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).

Authors:  Hiroyuki Yamaguchi; Shigeru Kamiya; Tomonori Uruma; Takako Osaki; Haruhiko Taguchi; Tomoko Hanawa; Minoru Fukuda; Hayato Kawakami; Hajime Goto; Herman Friedman; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

Review 6.  Implications for persistent chlamydial infections of phagocyte-microorganism interplay.

Authors:  I Sarov; E Geron; Y Shemer-Avni; E Manor; M Zvillich; D Wallach; E Schmitz; H Holtman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

7.  Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection.

Authors:  J M Penttilä; M Anttila; M Puolakkainen; A Laurila; K Varkila; M Sarvas; P H Mäkelä; N Rautonen
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 8.  Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.

Authors:  W L Beatty; R P Morrison; G I Byrne
Journal:  Microbiol Rev       Date:  1994-12

9.  Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment.

Authors:  K Laitinen; A L Laurila; M Leinonen; P Saikku
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

Review 10.  Recent advances in Chlamydia trachomatis.

Authors:  S Ladany; I Sarov
Journal:  Eur J Epidemiol       Date:  1985-12       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.